Pet Allergy Treatment Market Size & Share Analysis - Growth, Trends, and Forecasts (2024 - 2029)

Pet Allergy Treatment Market Analysis

The Pet Allergy Treatment Market size is estimated at USD 2.20 billion in 2024, and is expected to reach USD 2.9 billion by 2029, growing at a CAGR of 5.97% during the forecast period (2024-2029).

Pets, especially dogs, can be allergic to food, fleas, and airborne allergens like pollen, dust mites, and mold. This can lead to respiratory issues like coughing, sneezing, and wheezing. The key driving factors are the rising prevalence of atopic dermatitis, growing allergy awareness, rising adoption of pet health insurance, and rising pet ownership, increasing the potential for the pet allergy treatment market.

In recent years, the prevalence of atopic dermatitis among the canine population has increased and is expected to enhance the market's growth. For instance, according to data published in the Journal of Veterinary Medicine in February 2024, atopic dermatitis, a chronic allergic skin condition, is prevalent in dogs, impacting 20-30% of the canine population. This makes it the third most common health issue for dogs, impacting a much larger group of those experiencing skin problems. This widespread condition translates to a significant market demand for effective allergy treatments, fueling the growth of the pet allergy treatment market.

The market for pet allergy treatment is expected to continue expanding as the investment in innovative therapeutics for allergic disorders in animals is increasing. For instance, according to a study published in the Journal of Veterinary Sciences in November 2023, epicutaneous immunotherapy (EPIT) can revolutionize compliance with its painless and easy-to-use application directly on the skin. Therefore, innovation-enhancing treatments such as EPIT show a promising alternative that drives the market's growth by offering more precise and safe solutions for canine atopic dermatitis treatment.

Manufacturers are recognizing the importance of developing products and are highly focused on regulatory approvals to expand their product offerings. For instance, in June 2023, Zoetis Inc. secured FDA approval for Apoquel Chewable (oclacitinib chewable tablet). This innovative new treatment offers a convenient and potentially more compliant option for managing allergic dermatitis and atopic dermatitis in dogs twelve months of age and older.

Thus, the pet allergy treatment market is fueled by factors such as the soaring popularity of pet ownership, particularly dogs, creating a larger pool of animals potentially triggering allergies and approval of new products. However, limited accessibility, affordability, and regulatory hurdles are expected to challenge the market's growth.

Pet Allergy Treatment Market Trends

The Dogs Segment is Expected to Witness Significant Growth During the Forecast Period

Pet Allergy Treatment Industry Segmentation

Pets can be allergic to a variety of substances known as allergens, which include plant particles and other airborne or food-borne substances. Allergens are substances inhaled or absorbed by the skin, respiratory system, or gastrointestinal tract. These reactions result in skin redness, swelling, and itching.

The pet allergy treatment market is segmented into drug class, pet type, route of administration, and geography. By drug class, the market is segmented into antihistamines, corticosteroids, immunotherapy, and other drug classes (nasal irrigation, decongestants, etc.). By pet type, the market is segmented into dogs, cats, rabbits, and other pet types (rodents, horses, etc.). By route of administration, the market is segmented into oral, injectable, and topical. By geography, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa. The report also offers the market size and forecasts for 17 countries across the region. For each segment, the market sizing and forecasts were made on the basis of value (USD).